SEC Info - Unitedhealth Group Inc - ‘10-K’ for 12/31/19

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.43M 
 2: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     34K 
 3: EX-10.17    Material Contract                                   HTML    217K 
 4: EX-10.18    Material Contract                                   HTML     38K 
 5: EX-10.44    Material Contract                                   HTML     73K 
 6: EX-10.45    Material Contract                                   HTML     36K 
 7: EX-10.46    Material Contract                                   HTML     37K 
 8: EX-21.1     Subsidiaries List                                   HTML    298K 
 9: EX-23.1     Consent of Experts or Counsel                       HTML     32K 
10: EX-24.1     Power of Attorney                                   HTML     39K 
11: EX-31.1     Certification -- §302 - SOA'02                      HTML     46K 
12: EX-32.1     Certification -- §906 - SOA'02                      HTML     35K 
22: R1          Cover Document                                      HTML     96K 
79: R2          Consolidated Balance Sheets                         HTML    133K 
89: R3          Consolidated Balance Sheet (Parenthetical)          HTML     58K 
59: R4          Consolidated Statements of Operations               HTML    107K 
23: R5          Consolidated Statements of Comprehensive Income     HTML     76K 
80: R6          Consolidated Statements of Changes in Equity        HTML    109K 
90: R7          Consolidated Statement of Changes in Equity         HTML     33K 
                (Parentheticals)                                                 
58: R8          Consolidated Statements of Cash Flows               HTML    132K 
24: R9          Description of Business (Notes)                     HTML     32K 
108: R10         Basis of Presentation, Uses of Estimates and        HTML     96K  
                Significant Accounting Policies (Notes)                          
75: R11         Investments (Notes)                                 HTML    213K 
40: R12         Fair Value (Notes)                                  HTML    151K 
53: R13         Property, Plant, and Capitalized Software (Notes)   HTML     54K 
109: R14         Goodwill and Intangible Assets (Notes)              HTML    115K  
76: R15         Medical Costs Payable (Notes)                       HTML     81K 
41: R16         Commercial Paper and Long-Term Debt (Notes)         HTML    260K 
54: R17         Income Taxes (Notes)                                HTML    163K 
110: R18         Shareholders' Equity (Notes)                        HTML     51K  
74: R19         Share-Based Compensation (Notes)                    HTML    110K 
19: R20         Commitments and Contingencies (Notes)               HTML     54K 
55: R21         Business Combinations Business Combinations         HTML     44K 
                (Notes)                                                          
92: R22         Segment Financial Information (Notes)               HTML    308K 
81: R23         Quarterly Financial Data (Unaudited) (Notes)        HTML     82K 
20: R24         Schedule I (Notes)                                  HTML    202K 
56: R25         Basis of Presentation, Uses of Estimates and        HTML    153K 
                Significant Accounting Policies (Policies)                       
93: R26         Fair Value Fair Value (Policies)                    HTML     44K 
82: R27         Schedule I (Policies)                               HTML    122K 
18: R28         Basis of Presentation, Uses of Estimates and        HTML     71K 
                Significant Accounting Policies (Tables)                         
57: R29         Investments (Tables)                                HTML    209K 
52: R30         Fair Value (Tables)                                 HTML    143K 
38: R31         Property, Plant, and Capitalized Software (Tables)  HTML     52K 
78: R32         Goodwill and Intangible Assets (Tables)             HTML    122K 
112: R33         Medical Costs Payable (Tables)                      HTML     83K  
51: R34         Commercial Paper and Long-Term Debt (Tables)        HTML    262K 
37: R35         Income Taxes (Tables)                               HTML    165K 
77: R36         Shareholders' Equity (Tables)                       HTML     49K 
111: R37         Share-Based Compensation (Tables)                   HTML    115K  
49: R38         Commitments and Contingencies (Tables)              HTML     45K 
39: R39         Business Combinations Business Combinations         HTML     41K 
                (Tables)                                                         
65: R40         Segment Financial Information (Tables)              HTML    300K 
28: R41         Quarterly Financial Data (Unaudited) (Tables)       HTML     82K 
85: R42         Schedule I (Tables)                                 HTML    208K 
95: R43         Basis of Presentation, Uses of Estimates and        HTML     96K 
                Significant Accounting Policies (Details)                        
63: R44         Basis of Presentation, Uses of Estimates and        HTML     43K 
                Significant Accounting Policies Useful lives for                 
                property, equipment and capitalized software                     
                (Details)                                                        
27: R45         Basis of Presentation, Uses of Estimates and        HTML     56K 
                Significant Accounting Policies Redeemable                       
                Noncontrolling Interests (Details)                               
84: R46         Investments (Narrative) (Details)                   HTML     42K 
94: R47         Investments (Short-Term and Long-Term Investments)  HTML     82K 
                (Details)                                                        
62: R48         Investments (Amortized Cost and Fair Value of       HTML    104K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
29: R49         Investments (Fair Value of Available-For-Sale       HTML     67K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
35: R50         Fair Value (Narrative) (Details)                    HTML     39K 
46: R51         Fair Value (Financial Assets and Liabilities,       HTML     88K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
100: R52         Fair Value (Financial Assets and Liabilities, Not   HTML     56K  
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
66: R53         Property, Plant, and Capitalized Software           HTML     36K 
                (Narrative) (Details)                                            
36: R54         Property, Plant, and Capitalized Software Property  HTML     56K 
                Plant and Equipment Table (Details)                              
47: R55         Goodwill and Intangible Assets (Narrative)          HTML     34K 
                (Details)                                                        
101: R56         Goodwill and Intangible Assets Changes in the       HTML     51K  
                Carrying Amount of Goodwill by Reporting Segment                 
                (Details)                                                        
67: R57         Goodwill and Intangible Assets Gross carrying       HTML     49K 
                value, accumulated amortization and net carrying                 
                value of intangible assets (Details)                             
34: R58         Goodwill and Intangible Assets Weighted-average     HTML     43K 
                useful lives assigned to finite-lived intangible                 
                assets acquired in business combinations (Details)               
48: R59         Goodwill and Intangible Assets Amortization         HTML     43K 
                Expense relating to Intangible Assets (Details)                  
96: R60         Medical Costs Payable (Narrative) (Details)         HTML     31K 
87: R61         Medical Costs Payable Rollforward (Details)         HTML     55K 
25: R62         Medical Costs Payable, Incurred and Paid Medical    HTML     46K 
                Cost Development (Details)                                       
60: R63         Commercial Paper and Long-Term Debt (Narrative)     HTML     61K 
                (Details)                                                        
98: R64         Commercial Paper and Long-Term Debt (Details)       HTML    210K 
88: R65         Commercial Paper and Long-Term Debt Maturities of   HTML     48K 
                commercial paper and long-term debt (Details)                    
26: R66         Income Taxes (Narrative) (Details)                  HTML     65K 
61: R67         Income Taxes Reconciliation of Provision for        HTML     49K 
                Income Taxes (Details)                                           
99: R68         Income Tax Reconciliation of the tax provision at   HTML     86K 
                the U.S. Federal Statutory Rate (Details)                        
86: R69         Income Taxes Components of Deferred Tax Assets and  HTML     90K 
                Liabilities (Details)                                            
71: R70         Income Taxes Reconciliation of the beginning and    HTML     46K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
107: R71         Shareholders' Equity (Narrative) (Details)          HTML     43K  
45: R72         Shareholders' Equity Share Repurchases (Details)    HTML     42K 
33: R73         Share-Based Compensation (Narrative) (Details)      HTML     38K 
68: R74         Share-Based Compensation (Stock Option Activity)    HTML     80K 
                (Details)                                                        
104: R75         Share-Based Compensation (Restricted Share          HTML     48K  
                Activity) (Details)                                              
42: R76         Share-Based Compensation Other Share-Based          HTML     63K 
                Compensation Data (Details)                                      
30: R77         Share-Based Compensation (Share-Based Compensation  HTML     58K 
                Principal Fair Value Assumptions) (Details)                      
73: R78         Commitments and Contingencies (Narrative)           HTML     47K 
                (Details)                                                        
103: R79         Commitments and Contingencies Future Lease          HTML     55K  
                Payments (Details)                                               
70: R80         Business Combinations Acquired Assets and           HTML     49K 
                Liabilities (Details)                                            
106: R81         Business Combinations Business Combinations         HTML     39K  
                (Details)                                                        
44: R82         Segment Financial Information (Narrative)           HTML     45K 
                (Details)                                                        
32: R83         Segment Financial Information (Details)             HTML    125K 
69: R84         Quarterly Financial Data (Unaudited) (Details)      HTML     70K 
105: R85         Schedule I (Details)                                HTML     43K  
43: R86         Schedule I Condensed Balance Sheets (Details)       HTML    113K 
31: R87         Schedule I Balance Sheet Document (Details)         HTML     52K 
72: R88         Schedule I Condensed Statement of Comprehensive     HTML     73K 
                Income (Details)                                                 
102: R89         Schedule I Statement of Cash Flows (Details)        HTML    109K  
97: R90         Schedule I Maturities of Commercial Paper and       HTML     52K 
                Long-Term Debt (Details)                                         
50: XML         IDEA XML File -- Filing Summary                      XML    203K 
64: XML         XBRL Instance -- unh2019123110-k_htm                 XML   5.37M 
83: EXCEL       IDEA Workbook of Financial Reports                  XLSX    133K 
14: EX-101.CAL  XBRL Calculations -- unh-20191231_cal                XML    310K 
15: EX-101.DEF  XBRL Definitions -- unh-20191231_def                 XML   1.42M 
16: EX-101.LAB  XBRL Labels -- unh-20191231_lab                      XML   2.46M 
17: EX-101.PRE  XBRL Presentations -- unh-20191231_pre               XML   1.68M 
13: EX-101.SCH  XBRL Schema -- unh-20191231                          XSD    232K 
91: JSON        XBRL Instance as JSON Data -- MetaLinks              515±   798K 
21: ZIP         XBRL Zipped Folder -- 0000731766-20-000006-xbrl      Zip    654K

‘R16’ — Commercial Paper and Long-Term Debt (Notes)

This is an IDEA Financial Report. [ Alternative Formats ]

Commercial Paper and Long-Term Debt (Notes)

12 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Commercial Paper and Long-Term Debt [Text Block]

Commercial Paper and Long-Term Debt

Commercial paper and senior unsecured long-term debt consisted of the following:



	December 31, 2019						December 31, 2018
(in millions, except percentages)	Par Value		Carrying Value		Fair Value		Par Value		Carrying Value		Fair Value
Commercial paper	$	400	$	400	$	400	$	—	$	—	$	—
1.700% notes due February 2019	—		—		—		750		750		749
1.625% notes due March 2019	—		—		—		500		500		499
2.300% notes due December 2019	—		—		—		500		494		497
2.700% notes due July 2020	1,500		1,499		1,506		1,500		1,498		1,494
Floating rate notes due October 2020	300		300		300		300		299		298
3.875% notes due October 2020	450		450		455		450		443		456
1.950% notes due October 2020	900		899		900		900		897		884
4.700% notes due February 2021	400		403		410		400		398		412
2.125% notes due March 2021	750		749		753		750		747		734
Floating rate notes due June 2021	350		349		350		350		349		347
3.150% notes due June 2021	400		399		407		400		399		400
3.375% notes due November 2021	500		501		512		500		489		503
2.875% notes due December 2021	750		753		765		750		735		748
2.875% notes due March 2022	1,100		1,087		1,121		1,100		1,051		1,091
3.350% notes due July 2022	1,000		998		1,036		1,000		997		1,005
2.375% notes due October 2022	900		896		911		900		894		872
0.000% notes due November 2022	15		13		14		15		12		13
2.750% notes due February 2023	625		624		638		625		602		611
2.875% notes due March 2023	750		770		770		750		750		739
3.500% notes due June 2023	750		747		786		750		746		756
3.500% notes due February 2024	750		746		792		750		745		755
2.375% notes due August 2024	750		747		760		—		—		—
3.750% notes due July 2025	2,000		1,990		2,161		2,000		1,989		2,025
3.700% notes due December 2025	300		298		325		300		298		303
3.100% notes due March 2026	1,000		996		1,048		1,000		995		965
3.450% notes due January 2027	750		746		804		750		746		742
3.375% notes due April 2027	625		620		667		625		619		611
2.950% notes due October 2027	950		939		988		950		938		898
3.850% notes due June 2028	1,150		1,142		1,269		1,150		1,142		1,163
3.875% notes due December 2028	850		843		941		850		842		861
2.875% notes due August 2029	1,000		993		1,029		—		—		—
4.625% notes due July 2035	1,000		992		1,215		1,000		992		1,060
5.800% notes due March 2036	850		838		1,129		850		838		1,003
6.500% notes due June 2037	500		492		712		500		492		638
6.625% notes due November 2037	650		641		940		650		641		841
6.875% notes due February 2038	1,100		1,076		1,631		1,100		1,076		1,437
3.500% notes due August 2039	1,250		1,241		1,313		—		—		—
5.700% notes due October 2040	300		296		396		300		296		355
5.950% notes due February 2041	350		345		475		350		345		426
4.625% notes due November 2041	600		589		716		600		588		627
4.375% notes due March 2042	502		484		580		502		484		503
3.950% notes due October 2042	625		607		688		625		607		596
4.250% notes due March 2043	750		735		856		750		734		744
4.750% notes due July 2045	2,000		1,973		2,463		2,000		1,973		2,116
4.200% notes due January 2047	750		738		861		750		738		745
4.250% notes due April 2047	725		717		839		725		717		719
3.750% notes due October 2047	950		934		1,023		950		933		869
4.250% notes due June 2048	1,350		1,330		1,569		1,350		1,329		1,349
4.450% notes due December 2048	1,100		1,086		1,316		1,100		1,087		1,132
3.700% notes due August 2049	1,250		1,235		1,344		—		—		—
3.875% notes due August 2059	1,250		1,228		1,350		—		—		—
Total commercial paper and long-term debt	$	39,817	$	39,474	$	44,234	$	35,667	$	35,234	$	36,591

The Company’s long-term debt obligations also included $1.2 billion and $1.3 billion of other financing obligations, of which $322 million and $229 million were current as of December 31, 2019 and 2018, respectively.

Maturities of commercial paper and long-term debt for the years ending December 31 are as follows:



(in millions)
2020	$	3,870
2021	3,325
2022	3,190
2023	2,300
2024	1,675
Thereafter	26,660

Commercial Paper and Revolving Bank Credit Facilities

Commercial paper consists of short-duration, senior unsecured debt privately placed on a discount basis through broker-dealers.

The Company has $4.4 billion five-year, $4.4 billion three-year and $3.8 billion 364-day revolving bank credit facilities with 25 banks, which mature in December 2024, December 2022 and December 2020, respectively. These facilities provide liquidity support for the Company’s commercial paper program and are available for general corporate purposes. As of December 31, 2019, no amounts had been drawn on any of the bank credit facilities. The annual interest rates, which are variable based on term, are calculated based on the London Interbank Offered Rate (LIBOR) plus a credit spread based on the Company’s senior unsecured credit ratings. If amounts had been drawn on the bank credit facilities as of December 31, 2019, annual interest rates would have ranged from 2.4% to 2.6%.

Debt Covenants

The Company’s bank credit facilities contain various covenants, including requiring the Company to maintain a debt to debt-plus-shareholders’ equity ratio of not more than 60%. The Company was in compliance with its debt covenants as of December 31, 2019.

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-K’ Filing	Date	Other Filings

Filed on:	2/14/20	SC 13G
For Period end:	12/31/19	11-K
	12/31/18	10-K, 11-K, 4
		List all Filings

16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  UnitedHealth Group Inc.           10-K       12/31/23  119:19M
 3/03/23  UnitedHealth Group Inc.           S-8         3/03/23    9:419K
 2/24/23  UnitedHealth Group Inc.           10-K       12/31/22  119:19M
 2/22/23  UnitedHealth Group Inc.           S-8         2/22/23    7:276K                                   Toppan Merrill/FA
10/26/22  UnitedHealth Group Inc.           424B5                  2:490K                                   Donnelley … Solutions/FA
10/25/22  UnitedHealth Group Inc.           424B5                  1:421K                                   Donnelley … Solutions/FA
10/03/22  UnitedHealth Group Inc.           S-8        10/03/22    7:438K                                   Toppan Merrill/FA
 8/18/22  UnitedHealth Group Inc.           S-8         8/18/22    5:89K                                    Donnelley … Solutions/FA
 5/18/22  UnitedHealth Group Inc.           424B5                  2:477K                                   Donnelley … Solutions/FA
 5/17/22  UnitedHealth Group Inc.           424B5                  1:403K                                   Donnelley … Solutions/FA
 2/15/22  UnitedHealth Group Inc.           10-K       12/31/21  113:19M
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    5:264K
10/29/21  UnitedHealth Group Inc.           S-8        10/29/21    4:175K
 5/18/21  UnitedHealth Group Inc.           424B5                  1:435K                                   Donnelley … Solutions/FA
 5/17/21  UnitedHealth Group Inc.           424B5                  1:407K                                   Donnelley … Solutions/FA
 3/01/21  UnitedHealth Group Inc.           10-K       12/31/20  107:17M

↑Top

Filing Submission 0000731766-20-000006 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Unitedhealth Group Inc – ‘10-K’ for 12/31/19 – ‘R16’

On: Friday, 2/14/20, at 5:18pm ET · For: 12/31/19 · Accession #: 731766-20-6 · File #: 1-10864

Previous ‘10-K’: ‘10-K’ on 2/12/19 for 12/31/18 · Next: ‘10-K’ on 3/1/21 for 12/31/20 · Latest: ‘10-K’ on 2/28/24 for 12/31/23 · 16 References:

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

‘R16’ — Commercial Paper and Long-Term Debt (Notes)

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

16 Subsequent Filings that Reference this Filing

Unitedhealth Group Inc – ‘10-K’ for 12/31/19 – ‘R16’

On: Friday, 2/14/20, at 5:18pm ET · For: 12/31/19 · Accession #: 731766-20-6 · File #: 1-10864

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘R16’ — Commercial Paper and Long-Term Debt (Notes)

This is an IDEA Financial Report. [ Alternative Formats ]

Dates Referenced Herein and Documents Incorporated by Reference

16 Subsequent Filings that Reference this Filing

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents